Analysis

Quantum Biopharma Ltd. Subordinate Voting Shares Class B (QNTM) Stock Analysis

Quantum Biopharma Ltd. Subordinate Voting Shares Class B investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to QNTM.

websiteQNTM/analysis/QNTM

Quantum Biopharma Ltd. Subordinate Voting Shares Class B

Quantum Biopharma Ltd. Subordinate Voting Shares Class B investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to QNTM.

Stock profile

Ticker

QNTM

Asset type

Stock

Market cap

$24.6M

Sector

Health Technology

Industry

Biotechnology

Currency

CAD

Ticker listings

Quantum Biopharma Ltd. Subordinate Voting Shares Class B may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • QNTM primary listing
  • 0K91
  • A2P8F1

Latest Quantum Biopharma Ltd. Subordinate Voting Shares Class B news

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis

AUSTIN, Texas, June 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : Multiple sclero...

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.

Disseminated on behalf of  Quantum BioPharma , may include paid advertisements. AUSTI...

Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital

Promising Early Data Strengthens Potential of Novel PET Technology to Advance Development of Lucid-MS for Multiple SclerosisTORONTO, May 18, 2026 (GLOBE NEWSWIRE) -- Quantum Bio...

Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026

TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA:...

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Cl...

TORONTO, April 22, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FR...

Research sections

Valuation

Review valuation context for Quantum Biopharma Ltd. Subordinate Voting Shares Class B.

Future growth

Review future growth context for Quantum Biopharma Ltd. Subordinate Voting Shares Class B.

Past performance

Review past performance context for Quantum Biopharma Ltd. Subordinate Voting Shares Class B.

Financial health

Review financial health context for Quantum Biopharma Ltd. Subordinate Voting Shares Class B.

Dividend

Review dividend context for Quantum Biopharma Ltd. Subordinate Voting Shares Class B.

Management

Review management context for Quantum Biopharma Ltd. Subordinate Voting Shares Class B.

Ownership

Review ownership context for Quantum Biopharma Ltd. Subordinate Voting Shares Class B.

Other information

Review other information context for Quantum Biopharma Ltd. Subordinate Voting Shares Class B.

Community

Review community context for Quantum Biopharma Ltd. Subordinate Voting Shares Class B.